Rottlerin decreases the number of effector cells that mainly infiltrate the skin in IMQ-treated mice. by Min Min (1337967)

Absence of adaptive immunity decreases tumor cell damage in MDR1A deficiency. by Eva Maria Hennenberg (4234018)

Gu-4 improves survival in septic rats and this improvement is accompanied by marked decrease of HMGB1 and TNF-α level in serum. by HuiTing Zhou (333755)

Insulin treatment, acute or chronic, does not alter the number of CHT proteins at the cell surface, their binding affinity or the maximal uptake of choline. by Katherine J. Fishwick (768451)

mGluR5 specifically decreased α1^ins currents in HEK293T cells through ERK signaling. by Zi-Yang Zhang (4988555)

Dynamics of CHT internalization are altered by acute insulin treatment. by Katherine J. Fishwick (768451)

Cell surface CHT levels are unchanged by altered PI3-Kinase signaling in non-depolarized cells. by Katherine J. Fishwick (768451)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC₅₀ = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …”

Phosphorylation of p66^Shc at Ser36 during reperfusion after ischemia was dependent on the duration of ischemia. by Meiying Yang (654532)

Dynamics of CHT trafficking are altered by LY294002 treatment. by Katherine J. Fishwick (768451)

Fig 9 - by Wenping Dong (3854437)

Subjects:

Fig 4 - by Wenping Dong (3854437)

Subjects:

Fig 8 - by Wenping Dong (3854437)

Subjects:

Fig 7 - by Wenping Dong (3854437)

Subjects:

Fig 3 - by Wenping Dong (3854437)

Subjects:

Fig 6 - by Wenping Dong (3854437)

Subjects:

Decrease of cell viability and alterations of cell membrane permeability by infection with rotavirus isolates. by Carlos A. Guerrero (1264551)

<i>In vitro</i> characterization of the mnuA::Tn and 0690::Tn mutants. by Aga E. Gelgie (17661720)

Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

“…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”

Results for RBC dominant clots: (A) time to recanalize <i>in vitro</i> model; (B) relative clot reduction; (C) RBC release; (D) relative clot degradation rate. by Sandra Thalerová (11434762)

Subjects: